TY - CHAP
T1 - ATM
T2 - Its Recruitment, Activation, Signalling and Contribution to Tumour Suppression
AU - Shibata, Atsushi
AU - Jeggo, Penny
N1 - Publisher Copyright:
© 2018, Springer International Publishing AG, part of Springer Nature.
PY - 2018
Y1 - 2018
N2 - DNA double strand breaks (DSBs) are a critical lesion for cancer etiology. Most cancer cells incur increased DNA breakage to enhance genomic instability. The DSB damage response encompasses pathways of repair and a signal transduction pathway. The ataxia telangiectasia mutated (ATM) kinase lies at the centre of the signalling response. ATM is not essential for the major DSB repair process in mammalian cells but influences DSB repair, including its accuracy, in multiple ways. ATM is activated by DSBs to promote cell cycle checkpoint arrest and apoptosis. There is mounting evidence that ATM is active endogenously and/or that it can be activated by non-DSB routes, including oxidative damage. It plays an important role in regulating cellular redox status. The tumour suppressor functions of ATM are discussed. Paradoxically, since elevated DSBs arise in cancer cells, despite being a tumour suppressor, pharmacological inhibition of ATM is a promising route for cancer therapy.
AB - DNA double strand breaks (DSBs) are a critical lesion for cancer etiology. Most cancer cells incur increased DNA breakage to enhance genomic instability. The DSB damage response encompasses pathways of repair and a signal transduction pathway. The ataxia telangiectasia mutated (ATM) kinase lies at the centre of the signalling response. ATM is not essential for the major DSB repair process in mammalian cells but influences DSB repair, including its accuracy, in multiple ways. ATM is activated by DSBs to promote cell cycle checkpoint arrest and apoptosis. There is mounting evidence that ATM is active endogenously and/or that it can be activated by non-DSB routes, including oxidative damage. It plays an important role in regulating cellular redox status. The tumour suppressor functions of ATM are discussed. Paradoxically, since elevated DSBs arise in cancer cells, despite being a tumour suppressor, pharmacological inhibition of ATM is a promising route for cancer therapy.
KW - Apoptosis
KW - Ataxia telangiectasia
KW - Cell cycle checkpoints
KW - DNA damage signalling
KW - DNA double-strand break repair
KW - Radiosensitivity
UR - http://www.scopus.com/inward/record.url?scp=85088853194&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088853194&partnerID=8YFLogxK
U2 - 10.1007/978-3-319-75836-7_6
DO - 10.1007/978-3-319-75836-7_6
M3 - Chapter
AN - SCOPUS:85088853194
T3 - Cancer Drug Discovery and Development
SP - 129
EP - 154
BT - Cancer Drug Discovery and Development
PB - Humana Press Inc.
ER -